Learn how the 12-year biologic exclusivity rule under the BPCIA delays biosimilar entry, impacting drug prices and patient access in the US compared to global markets.
Jul, 3 2026
Sep, 22 2025
Jan, 24 2026
Jan, 26 2026
Apr, 26 2025